MELODY MOORE: Open Payments
NPI 1790093730 · OLYMPIA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$259 in 12 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $243 · 2025 $259
Food & beverage: $259
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 3 | $73 |
| ABBVIE INC. | 3 | $63 |
| Axsome Therapeutics, Inc. | 2 | $43 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| Corium, LLC | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: VRAYLAR, ARISTADA, Auvelity, COBENFY, Azstarys, LYBALVI, TRINTELLIX.
Industry payments across WA — which companies pay providers there.
